Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-29
1995-12-05
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514269, 514317, 514318, 514319, 544333, 544405, 546184, 546194, 546205, 546206, 546236, A61K 31495, A61K 31505, A61K 31445
Patent
active
054729661
ABSTRACT:
Certain aminoalkyl derivatives of naphthyl-piperidines and tetrahydro-pyridines of Formula (I) are useful antidepressant agents. ##STR1## The symbol (Aryl) denotes phenyl, naphthyl, pyridinyl, pyrimidinyl and pyrazinyl ring systems with n being an integer of 2-4.
REFERENCES:
patent: 5166156 (1992-11-01), Lavielle et al.
patent: 5250544 (1993-10-01), Lavielle et al.
patent: 5292711 (1994-03-01), Nishimura et al.
patent: 5292761 (1994-03-01), Lavielle et al.
Glennon et al, "5-HT.sub.1D Serotonin Receptors: Results of a Structure-Affinity Investigation," Drug Development Research, 22:25-36 (1991).
Sloan Charles P.
Smith David W.
Bristol--Myers Squibb Company
Ivy C. Warren
Owens Amelia
Ryan Richard P.
LandOfFree
Antidepressant heteroarylaminoalkyl derivatives of naphthyl-mona does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidepressant heteroarylaminoalkyl derivatives of naphthyl-mona, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressant heteroarylaminoalkyl derivatives of naphthyl-mona will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1374381